‘Some of Them Will Die’: Alabama Hit Hard by Monoclonal Antibody Rationing

The federal government's sudden rationing of monoclonal antibody treatments, which keep Americans who get COVID-19 out of hospitals, is hitting Alabama hard, with some sites already running out of or projected to run out of supply soon.

"Some entities are very low on product and some project running out of product over the weekend," Dr. Karen Landers, a health officer with the Alabama Department of Public Health, told The Epoch Times in an email on Friday.

The monoclonal antibody shortage will likely contribute to the issue.

The federal government has dominated the supply of monoclonal antibody treatments from Regeneron and Eli Lilly.

The new model has the government ration the doses, deciding how much to give each state.

Florida is the only state that has started the process of sourcing directly from GSK, according to health officials across the United States.

The federal government has locked up hundreds of thousands of doses of the Regeneron and Eli Lilly medicines, and GSK's is the only other monoclonal antibody treatment authorized for use at this time in the United States.
 

https://www.theepochtimes.com/some-of-them-will-die-alabama-hit-hard-by-monoclonal-antibody-rationing_4003285.html